Competition & Peer Data API & CSV Delivery

Emmaus Life Sciences Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Emmaus Life Sciences Inc (EMMA) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2019
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
579.24 %
Q1 2019
Net Margin
-266.69 %
Q1 2019

Key Findings: Emmaus Life Sciences Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 20M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+8.3% annualized vs trailing 12 months).
  • Peer revenue share: Emmaus Life Sciences Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

EMMA Sales vs. its Competitors, Q1 2019

Emmaus Life Sciences Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/EMMA/competitors
https://api.csimarket.com/api/v1/companies/EMMA/relationships
https://api.csimarket.com/api/v1/companies/EMMA/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Blank Checks industry grew revenue 7.6% year over year, combined, vs 579.2% for Emmaus Life Sciences Inc. Emmaus Life Sciences Inc's share of combined industry revenue moved from 0.02% to 0.14%, a gain of 0.12 percentage points.

Emmaus Life Sciences Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Emmaus Life Sciences, Inc. No Yes Yes No
Similar Growth & Profitability (8) 50.00 % (4 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 25.00 % (2 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q1 2019

100%market share
  • Emmaus Life Sciences Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Emmaus Life Sciences Inc and its 0 tracked competitors.

See Emmaus Life Sciences Inc's full market share breakdown »

EMMA Stock Performance relative to its Competitors

EMMA Competitors (weighted) Percent change over the selected range

EMMA Stock Performance relative to Similar Growth & Profitability Competitors

EMMA Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range